Skip to main content
search
Conference

Marbach DDI Workshop 2026

Conference: Marbach DDI Workshop 2026

Date: May 31 - June 2, 2026

Location: Marbach Castle, Öhningen, Germany

The 16th International Marbach Castle DDI Workshop brings together global leaders from industry, academia, and regulatory agencies to advance the science, regulation, and clinical application of drug-drug interactions (DDI).

This year’s workshop organizers include Certara’s Amin Rostami-Hodjegan, PhD, FCP, FAAPS, FJSSX and Isabelle Ragueneau-Majlessi, MD, MSc. Their roles highlight Certara’s longstanding scientific leadership in shaping global regulatory expectations and best practices for DDI assessment. Certara is proud to help lead and contribute to the dialogue that drives safer, more efficient drug development worldwide.

Where to hear Certara insights and expertise

Monday, June 1 | 9:15am-12:30pm
Session I: DDI Implementation from Bench to Bedside: Challenges and Opportunities

Chair: Isabelle Ragueneau-Majlessi, MD, MSc, Distinguished Scientist, Drug Interaction Solutions, Certara

Monday, June 1 | 2:00-5:00pm
Session II: The EMA PBPK Model Qualification Pathway

Chair: Amin Rostami-Hodjegan, PhD, FCP, FAAPS, FJSSX, CSO and SVP of R&D, Certara

Monday, June 1 | 2:30-3:00pm
The Roller-Coaster of Platform Qualification: The PBPK Case with DDI as Context of Use

Karen Rowland Yeo, PhD, SVP, Client and Regulatory Strategy, Certara

Tuesday, June 2 | 10:30-10:55am
An Integrated Approach to Enable Efficient Management of Complex DDIs in Global Health

Lisa Almond, PhD, Senior Director, PBPK Consultancy, Certara

Tuesday, June 2
Poster: An Evidence-based Approach for Managing DDI Risk for Patients in Clinical Trials

Jingjing Yu, MD, PhD, Director, Drug Interaction Solutions, Certara

Featured solutions:

Simcyp® Simulator

Industry-leading PBPK modeling software supporting PBPK applications across drug development, including DDI assessment, dosing in specific populations, first-in-human dose prediction, and formulation.

Learn more

Drug-interaction Database (DIDB®)

The industry’s largest scientist-curated database for assessing drug interactions and safety.

Learn more

You May Also Like

Mechanistic MIDD: Achieving Regulatory Success Through Strong Scientific Foundations
Mechanistic MIDD: Achieving Regulatory Success Through Strong Scientific FoundationsLive Events

Mechanistic MIDD: Achieving Regulatory Success Through Strong Scientific Foundations

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators
The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with RegulatorsOn-Demand Webinar

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Simcyp Focused Workshop: DDI (Predicting and evaluating complex DDIs) Japan
Simcyp Focused Workshop: DDI (Predicting and evaluating complex DDIs) JapanLive Events

Simcyp Focused Workshop: DDI (Predicting and evaluating complex DDIs) Japan

Fact Sheet

From first-in-human trials to global regulatory approvals and post-launch, Certara solutions can help you move your science forward faster, with confidence.

Download now